Bridgebio PharmaBBIO 
$26.732.06%24h
2.06%24h
Global rank2932
Market cap$4.65B
Change 7d4.58%
YTD Performance-32.79%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Bridgebio Pharma (BBIO)
As of November 2024, Bridgebio Pharma has a market cap of $4.65B. This makes Bridgebio Pharma the world's 2932th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Bridgebio Pharma from 2019 to 2024
-
Value:-
Market cap history of Bridgebio Pharma from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $6.75B | -3.89% |
| 2023 | $7.02B | 429.79% |
| 2022 | $1.33B | -54.32% |
| 2021 | $2.90B | -76.54% |
| 2020 | $12.37B | 102.88% |
| 2019 | $6.10B | - |
BBIO Market Cap Today is $4.65B 2.06% - 2 Nov 2024
View largest stocks by market cap 
